Evidence map›Paper›PMID 23483945›Full record

ArticlePloS one2013

Creation of resveratrol-enriched rice for the treatment of metabolic syndrome and related diseases.

So-Hyeon Baek, Woon-Chul Shin, Hak-Seung Ryu, Dae-Woo Lee, Eunjung Moon, Chun-Sun Seo, Eunson Hwang, Hyun-Seo Lee, Mi-Hyun Ahn, Youngju Jeon and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Natural Products in the Clinical Management of Metabolic Syndrome.Handbook of experimental pharmacology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tricin Biosynthesis and Bioengineering.Frontiers in plant science · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

So-Hyeon BaekNational Institute of Crop Science, Rural Development Administration, Iksan, Chonbuk, Korea.
Woon-Chul Shin
Hak-Seung Ryu
Dae-Woo Lee
Eunjung Moon
Chun-Sun Seo
Eunson Hwang
Hyun-Seo Lee
Mi-Hyun Ahn
Youngju Jeon
Hyeon-Jung Kang
Sang-Won Lee
Sun Yeou Kim
Roshan D'Souza
Hyeon-Jin Kim
Seong-Tshool Hong
Jong-Seong Jeon
Kyung Hee University · KRJeonbuk National University · KRRural Development Administration · KRJINIS Biopharmaceuticals (South Korea) · KRGachon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol has been clinically shown to possess a number of human health benefits. As a result, many attempts have been made to engineer resveratrol production in major cereal grains but have been largely unsuccessful. In this study, we report the creation of a transgenic rice plant that accumulates 1.9 µg resveratrol/g in its grain, surpassing the previously reported anti-metabolic syndrome activity of resveratrol through a synergistic interaction between the transgenic resveratrol and the endogenous properties of the rice. Consumption of our transgenic resveratrol-enriched rice significantly improved all aspects of metabolic syndrome and related diseases in animals fed a high-fat diet. Compared with the control animals, the resveratrol-enriched rice reduced body weight, blood glucose, triglycerides, total cholesterol, and LDL-cholesterol by 24.7%, 22%, 37.4%, 27%, and 59.6%, respectively. The resveratrol-enriched rice from our study may thus provide a safe and convenient means of preventing metabolic syndrome and related diseases without major lifestyle changes or the need for daily medications. These results also suggest that future transgenic plants could be improved if the synergistic interactions of the transgene with endogenous traits of the plant are considered in the experimental design.

Indexed as

Food, FortifiedAcyltransferasesAdipose TissueAnimalsBlood GlucoseBody WeightChromatography, High Pressure LiquidFemaleGlucosidesGlucosyltransferasesHumansLipidsMetabolic SyndromeMiceMice, Inbred C57BLOryzaAcyltransferasesBlood GlucoseGlucosidesGlucosyltransferasesLipidspolydatinResveratrolSirt1 protein, mouseSirtuin 1Stilbenesstilbene synthase

Identifiers

PMID23483945
PMCPMC3587571
OpenAlexW2018748422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.